Logo image of 1ELX.MI

ESTEE LAUDER COMPANIES-CL A (1ELX.MI) Stock Fundamental Analysis

BIT:1ELX - US5184391044 - Common Stock

78.2 EUR
-0.4 (-0.51%)
Last: 8/18/2025, 7:00:00 PM
Fundamental Rating

3

Overall 1ELX gets a fundamental rating of 3 out of 10. We evaluated 1ELX against 13 industry peers in the Personal Care Products industry. 1ELX may be in some trouble as it scores bad on both profitability and health. 1ELX is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

1ELX had positive earnings in the past year.
In the past year 1ELX had a positive cash flow from operations.
1ELX had positive earnings in 4 of the past 5 years.
1ELX had a positive operating cash flow in each of the past 5 years.
1ELX.MI Yearly Net Income VS EBIT VS OCF VS FCF1ELX.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B 3B

1.2 Ratios

1ELX's Return On Assets of -5.70% is on the low side compared to the rest of the industry. 1ELX is outperformed by 92.31% of its industry peers.
Looking at the Return On Equity, with a value of -29.31%, 1ELX is doing worse than 92.31% of the companies in the same industry.
The Return On Invested Capital of 1ELX (4.17%) is worse than 84.62% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for 1ELX is significantly below the industry average of 12.46%.
Industry RankSector Rank
ROA -5.7%
ROE -29.31%
ROIC 4.17%
ROA(3y)0.13%
ROA(5y)4.98%
ROE(3y)-1.32%
ROE(5y)17.24%
ROIC(3y)4.98%
ROIC(5y)7.4%
1ELX.MI Yearly ROA, ROE, ROIC1ELX.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

1.3 Margins

With a Operating Margin value of 7.94%, 1ELX is not doing good in the industry: 76.92% of the companies in the same industry are doing better.
1ELX's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 73.96%, 1ELX is in the better half of the industry, outperforming 76.92% of the companies in the same industry.
In the last couple of years the Gross Margin of 1ELX has remained more or less at the same level.
Industry RankSector Rank
OM 7.94%
PM (TTM) N/A
GM 73.96%
OM growth 3Y-26.29%
OM growth 5Y-11.55%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.76%
GM growth 5Y-0.3%
1ELX.MI Yearly Profit, Operating, Gross Margins1ELX.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60 80

3

2. Health

2.1 Basic Checks

1ELX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
1ELX has more shares outstanding than it did 1 year ago.
1ELX has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, 1ELX has a worse debt to assets ratio.
1ELX.MI Yearly Shares Outstanding1ELX.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
1ELX.MI Yearly Total Debt VS Total Assets1ELX.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

2.2 Solvency

An Altman-Z score of 3.06 indicates that 1ELX is not in any danger for bankruptcy at the moment.
The Altman-Z score of 1ELX (3.06) is comparable to the rest of the industry.
1ELX has a debt to FCF ratio of 10.92. This is a negative value and a sign of low solvency as 1ELX would need 10.92 years to pay back of all of its debts.
1ELX has a Debt to FCF ratio of 10.92. This is in the lower half of the industry: 1ELX underperforms 76.92% of its industry peers.
1ELX has a Debt/Equity ratio of 1.89. This is a high value indicating a heavy dependency on external financing.
1ELX's Debt to Equity ratio of 1.89 is on the low side compared to the rest of the industry. 1ELX is outperformed by 84.62% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.89
Debt/FCF 10.92
Altman-Z 3.06
ROIC/WACC0.55
WACC7.54%
1ELX.MI Yearly LT Debt VS Equity VS FCF1ELX.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B

2.3 Liquidity

1ELX has a Current Ratio of 1.30. This is a normal value and indicates that 1ELX is financially healthy and should not expect problems in meeting its short term obligations.
1ELX has a better Current ratio (1.30) than 61.54% of its industry peers.
1ELX has a Quick Ratio of 1.30. This is a bad value and indicates that 1ELX is not financially healthy enough and could expect problems in meeting its short term obligations.
1ELX has a better Quick ratio (0.92) than 61.54% of its industry peers.
Industry RankSector Rank
Current Ratio 1.3
Quick Ratio 0.92
1ELX.MI Yearly Current Assets VS Current Liabilites1ELX.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

4

3. Growth

3.1 Past

The earnings per share for 1ELX have decreased strongly by -42.31% in the last year.
Measured over the past years, 1ELX shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -18.22% on average per year.
1ELX shows a decrease in Revenue. In the last year, the revenue decreased by -8.24%.
Measured over the past years, 1ELX shows a small growth in Revenue. The Revenue has been growing by 0.04% on average per year.
EPS 1Y (TTM)-42.31%
EPS 3Y-40.77%
EPS 5Y-18.22%
EPS Q2Q%-85.94%
Revenue 1Y (TTM)-8.24%
Revenue growth 3Y-6.88%
Revenue growth 5Y0.04%
Sales Q2Q%-11.96%

3.2 Future

The Earnings Per Share is expected to grow by 28.94% on average over the next years. This is a very strong growth
Based on estimates for the next years, 1ELX will show a small growth in Revenue. The Revenue will grow by 3.33% on average per year.
EPS Next Y48.59%
EPS Next 2Y42.44%
EPS Next 3Y37.52%
EPS Next 5Y28.94%
Revenue Next Year3.27%
Revenue Next 2Y3.72%
Revenue Next 3Y4.19%
Revenue Next 5Y3.33%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
1ELX.MI Yearly Revenue VS Estimates1ELX.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B
1ELX.MI Yearly EPS VS Estimates1ELX.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 60.62 indicates a quite expensive valuation of 1ELX.
84.62% of the companies in the same industry are cheaper than 1ELX, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of 1ELX to the average of the S&P500 Index (27.13), we can say 1ELX is valued expensively.
A Price/Forward Earnings ratio of 40.90 indicates a quite expensive valuation of 1ELX.
Based on the Price/Forward Earnings ratio, 1ELX is valued more expensive than 84.62% of the companies in the same industry.
1ELX's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.76.
Industry RankSector Rank
PE 60.62
Fwd PE 40.9
1ELX.MI Price Earnings VS Forward Price Earnings1ELX.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

76.92% of the companies in the same industry are cheaper than 1ELX, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, 1ELX is valued a bit more expensive than the industry average as 76.92% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 48.97
EV/EBITDA 18.92
1ELX.MI Per share data1ELX.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
1ELX's earnings are expected to grow with 37.52% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.25
PEG (5Y)N/A
EPS Next 2Y42.44%
EPS Next 3Y37.52%

3

5. Dividend

5.1 Amount

1ELX has a Yearly Dividend Yield of 1.53%.
1ELX's Dividend Yield is slightly below the industry average, which is at 2.43.
1ELX's Dividend Yield is slightly below the S&P500 average, which is at 2.32.
Industry RankSector Rank
Dividend Yield 1.53%

5.2 History

The dividend of 1ELX is nicely growing with an annual growth rate of 9.59%!
Dividend Growth(5Y)9.59%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

The earnings of 1ELX are negative and hence is the payout ratio. 1ELX will probably not be able to sustain this dividend level.
1ELX's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-54.55%
EPS Next 2Y42.44%
EPS Next 3Y37.52%
1ELX.MI Yearly Income VS Free CF VS Dividend1ELX.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B

ESTEE LAUDER COMPANIES-CL A

BIT:1ELX (8/18/2025, 7:00:00 PM)

78.2

-0.4 (-0.51%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)08-20 2025-08-20/bmo
Earnings (Next)10-31 2025-10-31/bmo
Inst Owners94.25%
Inst Owner ChangeN/A
Ins Owners0.13%
Ins Owner ChangeN/A
Market Cap28.14B
Analysts68.33
Price Target72.61 (-7.15%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.53%
Yearly Dividend2.27
Dividend Growth(5Y)9.59%
DP-54.55%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)49.72%
Min EPS beat(2)0.44%
Max EPS beat(2)99.01%
EPS beat(4)4
Avg EPS beat(4)57.77%
Min EPS beat(4)0.44%
Max EPS beat(4)99.01%
EPS beat(8)8
Avg EPS beat(8)83.43%
EPS beat(12)11
Avg EPS beat(12)80.65%
EPS beat(16)15
Avg EPS beat(16)63.88%
Revenue beat(2)0
Avg Revenue beat(2)-2.31%
Min Revenue beat(2)-2.6%
Max Revenue beat(2)-2.01%
Revenue beat(4)0
Avg Revenue beat(4)-2.46%
Min Revenue beat(4)-3.22%
Max Revenue beat(4)-2.01%
Revenue beat(8)0
Avg Revenue beat(8)-2.21%
Revenue beat(12)1
Avg Revenue beat(12)-1.91%
Revenue beat(16)3
Avg Revenue beat(16)-1.8%
PT rev (1m)4.78%
PT rev (3m)4.19%
EPS NQ rev (1m)-27.37%
EPS NQ rev (3m)-47.42%
EPS NY rev (1m)-2.47%
EPS NY rev (3m)-8.63%
Revenue NQ rev (1m)1.28%
Revenue NQ rev (3m)0.4%
Revenue NY rev (1m)0.72%
Revenue NY rev (3m)-0.2%
Valuation
Industry RankSector Rank
PE 60.62
Fwd PE 40.9
P/S 2.29
P/FCF 48.97
P/OCF 25.79
P/B 8.49
P/tB N/A
EV/EBITDA 18.92
EPS(TTM)1.29
EY1.65%
EPS(NY)1.91
Fwd EY2.44%
FCF(TTM)1.6
FCFY2.04%
OCF(TTM)3.03
OCFY3.88%
SpS34.14
BVpS9.21
TBVpS-4.84
PEG (NY)1.25
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.7%
ROE -29.31%
ROCE 7.86%
ROIC 4.17%
ROICexc 5.22%
ROICexgc 10.68%
OM 7.94%
PM (TTM) N/A
GM 73.96%
FCFM 4.68%
ROA(3y)0.13%
ROA(5y)4.98%
ROE(3y)-1.32%
ROE(5y)17.24%
ROIC(3y)4.98%
ROIC(5y)7.4%
ROICexc(3y)6.37%
ROICexc(5y)9.94%
ROICexgc(3y)15.14%
ROICexgc(5y)22.74%
ROCE(3y)9.4%
ROCE(5y)13.97%
ROICexcg growth 3Y-33.25%
ROICexcg growth 5Y-18.06%
ROICexc growth 3Y-32.16%
ROICexc growth 5Y-18.64%
OM growth 3Y-26.29%
OM growth 5Y-11.55%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.76%
GM growth 5Y-0.3%
F-Score4
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 1.89
Debt/FCF 10.92
Debt/EBITDA 3.72
Cap/Depr 72.62%
Cap/Sales 4.2%
Interest Coverage 3.22
Cash Conversion 64.7%
Profit Quality N/A
Current Ratio 1.3
Quick Ratio 0.92
Altman-Z 3.06
F-Score4
WACC7.54%
ROIC/WACC0.55
Cap/Depr(3y)208.69%
Cap/Depr(5y)173.4%
Cap/Sales(3y)10.24%
Cap/Sales(5y)8.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-42.31%
EPS 3Y-40.77%
EPS 5Y-18.22%
EPS Q2Q%-85.94%
EPS Next Y48.59%
EPS Next 2Y42.44%
EPS Next 3Y37.52%
EPS Next 5Y28.94%
Revenue 1Y (TTM)-8.24%
Revenue growth 3Y-6.88%
Revenue growth 5Y0.04%
Sales Q2Q%-11.96%
Revenue Next Year3.27%
Revenue Next 2Y3.72%
Revenue Next 3Y4.19%
Revenue Next 5Y3.33%
EBIT growth 1Y-27.35%
EBIT growth 3Y-31.36%
EBIT growth 5Y-11.51%
EBIT Next Year100.09%
EBIT Next 3Y38.66%
EBIT Next 5Y28.47%
FCF growth 1Y-53.5%
FCF growth 3Y-30.55%
FCF growth 5Y-16.56%
OCF growth 1Y-46.1%
OCF growth 3Y-25.21%
OCF growth 5Y-11.02%